Tompkins Financial (TMP) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Executive summary
The annual meeting is scheduled for May 13, 2025, with voting on director elections, executive compensation, and auditor ratification.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact.
Shareholders of record as of March 17, 2025, are eligible to vote; 14,434,103 shares are outstanding.
Voting matters and shareholder proposals
Shareholders will vote on electing 11 directors for one-year terms, an advisory say-on-pay vote, and ratification of KPMG LLP as auditor.
Board recommends voting “FOR” all proposals; a plurality is required for director elections, and a majority for the other proposals.
Shareholder proposals for the 2026 meeting must be submitted by December 2, 2025.
Board of directors and corporate governance
Eleven director nominees include a mix of incumbents and new candidates, with diverse backgrounds and skills.
Board committees include Executive, Compensation, Audit & Risk, and Nominating & Corporate Governance, all with independent directors.
Annual board self-assessments and director education are conducted; majority of the board is independent.
Corporate governance guidelines prohibit significant pledging or hedging of company stock by directors and executives.
Latest events from Tompkins Financial
- Q2 2024 net income and EPS surged 85% year-over-year, with strong loan growth and capital ratios.TMP
Q2 202412 Mar 2026 - Q3 2024 net income rebounded to $18.6M, driven by loan growth and higher fee-based revenue.TMP
Q3 202412 Mar 2026 - Earnings surged year-over-year on broad revenue growth, improved margins, and lower expenses.TMP
Q4 202412 Mar 2026 - Net income and EPS up over 16% year-over-year, with strong revenue and robust capital ratios.TMP
Q1 202512 Mar 2026 - Q2 2025 net income and EPS surged, with strong margins and new shareholder returns announced.TMP
Q2 202512 Mar 2026 - Q3 2025 net income up 27% and EPS up 26.9%, with margin gains and a 4.6% dividend increase.TMP
Q3 202512 Mar 2026 - Record earnings and capital gains from insurance sale, with robust loan and deposit growth.TMP
Q4 202512 Mar 2026 - Dividend reinvestment and stock purchase plan offers direct, low-fee share acquisition for investors.TMP
Registration Filing12 Mar 2026 - Dividend reinvestment and stock purchase plan offers up to 294,163 shares with low investor fees.TMP
Registration Filing12 Mar 2026